GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Ending Cash Position

Nextage Therapeutics (XTAE:NXTG) Ending Cash Position : ₪0.40 Mil (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Ending Cash Position?

Nextage Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was ₪0.40 Mil.

Nextage Therapeutics's quarterly Ending Cash Position declined from Dec. 2022 (₪1.05 Mil) to Jun. 2023 (₪0.00 Mil) but then increased from Jun. 2023 (₪0.00 Mil) to Dec. 2023 (₪0.40 Mil).

Nextage Therapeutics's annual Ending Cash Position declined from Dec. 2021 (₪3.26 Mil) to Dec. 2022 (₪1.05 Mil) and declined from Dec. 2022 (₪1.05 Mil) to Dec. 2023 (₪0.40 Mil).


Nextage Therapeutics Ending Cash Position Historical Data

The historical data trend for Nextage Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Ending Cash Position Chart

Nextage Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 0.92 2.03 3.26 1.05 0.40

Nextage Therapeutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.26 3.63 1.05 - 0.40

Nextage Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nextage Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.051+-0.647
=0.40

Nextage Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.0030000000000001+0.401
=0.40


Nextage Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Nextage Therapeutics (XTAE:NXTG) Business Description

Traded in Other Exchanges
N/A
Address
Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines